LAS VEGAS--(BUSINESS WIRE)--March 21, 2006--Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today its Alzheimer's adult stem cell drug SP-sc04, which induces dormant brain neuronal stem cells to differentiate rapidly into adult neuron cells, is progressing through preclinical studies with promising results.
